This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
BG Q2 Earnings Beat, Revenues Down Y/Y on Weak Results Across Segments
by Zacks Equity Research
Bunge Global's Q2 profit beats estimates but slides 24% as weak segment results offset gains from lower costs.
Here's What Key Metrics Tell Us About Bunge Global (BG) Q2 Earnings
by Zacks Equity Research
Although the revenue and EPS for Bunge Global (BG) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Bunge Global (BG) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Bunge Global (BG) delivered earnings and revenue surprises of +10.08% and +12.45%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Bunge Ready to Report Q2 Earnings: What's in Store for the Stock?
by Zacks Equity Research
BG's Q2 performance is expected to have been weak, with earnings declining 31% y/y and sales falling 14% amid weaker agribusiness volumes and margins.
Company News for Jul 8, 2025
by Zacks Equity Research
Companies in The News Are: BG, ON, LULU, PEG
Bunge & Viterra Close Merger, Form Global Agribusiness Powerhouse
by Zacks Equity Research
BG merges with Viterra, creating a global agribusiness giant set to boost earnings, synergies and supply-chain reach.
3 Agriculture - Products Stocks to Watch Despite Industry Concerns
by Madhurima Das
The near-term outlook for the Zacks Agriculture - Products industry is uncertain. Stocks like BG, CALM and HYFM are braving the industry headwinds.
Bunge Overcomes Final Regulatory Hurdle to Viterra Merger
by Zacks Equity Research
BG clears final Chinese regulatory hurdle, setting the stage to close the $34B Viterra merger by early July.
BG Q1 Earnings Beat, Revenues Down Y/Y on Weak Results Across Segments
by Zacks Equity Research
Bunge Global reports a 41% decline in earnings in Q1. The company's 2025 earnings per share guidance of $7.75 indicates a 15.7% year-over-year decline.
Bunge Global (BG) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Bunge Global (BG) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Bunge Global (BG) Beats Q1 Earnings Estimates
by Zacks Equity Research
Bunge Global (BG) delivered earnings and revenue surprises of 42.52% and 9.10%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Bunge Gears Up to Report Q1 Earnings: What's in Store for the Stock?
by Zacks Equity Research
BG's Q1 results are anticipated to reflect weak year-over-year performances in its segments and the impacts of the divestiture of the Sugar and Bioenergy segment.
Curious about Bunge Global (BG) Q1 Performance? Explore Wall Street Estimates for Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Bunge Global (BG), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2025.
Bunge Global Inks Deal to Sell North America Corn Milling Business
by Zacks Equity Research
BG plans to sell its North America Corn milling business to focus better on core businesses.
CALM Q3 Earnings & Sales Surge Y/Y on High Egg Prices & Demand
by Zacks Equity Research
Cal-Maine Food's solid third-quarter fiscal 2025 results reflect the impacts of the higher net average selling price of eggs and robust seasonal demand.
BG Inks Deal to Sell European Margarines and Spreads Business
by Zacks Equity Research
Bunge Global is selling its European margarines and spreads business to focus on core operations.
GrowGeneration Q4 Earnings Miss Estimates, Revenues Decrease Y/Y
by Zacks Equity Research
GRWG's Q4 top line reflects the impacts of 19 fewer retail locations in 2024.
BG Earnings & Sales Miss Estimates in Q4, EPS Plunges 42% Y/Y
by Zacks Equity Research
Bunge Global reports a 33% decline in earnings in 2024. The company's projection of earnings per share of $7.75 for 2025 indicates a 15.7% year-over-year decline.
Bunge Global (BG) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Bunge Global (BG) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Bunge Global (BG) Lags Q4 Earnings Estimates
by Zacks Equity Research
Bunge Global (BG) delivered earnings and revenue surprises of -7.39% and 5.80%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Bunge Gears Up to Report Q4 Earnings: Here's What to Expect
by Zacks Equity Research
BG's Q4 results are anticipated to reflect weak year-over-year performances in its segments and the impacts of the divestiture of the Sugar and Bioenergy segment.
Analysts Estimate Bunge Global (BG) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Bunge Global (BG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
5 Broker-Loved Stocks to Monitor Amid Signs of Slowing Inflation
by Maharathi Basu
Investors should keep a tab on stocks like National Vision, Cencora, ABM, Arrow Electronics and Bunge Global for high returns.
Bunge & Viterra Merger Cleared by Canada Government, Set to Close Soon
by Zacks Equity Research
The government of Canada gives the green light to the BG -Viterra merger, subject to certain conditions.
Implied Volatility Surging for Bunge Global (BG) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Bunge Global (BG) stock based on the movements in the options market lately.